marks published for opposition - U.S. Patent and Trademark Office

TM 148 OFFICIAL GAZETTE JULY 17, 2012
SN 85-235,891. WHG PROPERTIES, LLC, NORRISTOWN,
MN. FILED 2-7-2011.
THE MARK CONSISTS OF A STYLIZED DEPICTION OF
THE LETTER "G".
CLASS 13—FIREARMS
FOR TRIGGERS FOR FIREARMS (U.S. CLS. 2 AND 9).
FIRST USE 12-0-2010; IN COMMERCE 12-0-2010.
CLASS 16—PAPER GOODS AND PRINTED
MATTER
FOR STICKERS (U.S. CLS. 2, 5, 22, 23, 29, 37, 38 AND
50).
FIRST USE 12-0-2010; IN COMMERCE 12-0-2010.
CLASS 26—FANCY GOODS
FOR ORNAMENTAL CLOTH PATCHES (U.S. CLS. 37,
39, 40, 42 AND 50).
FIRST USE 12-0-2010; IN COMMERCE 12-0-2010.
CLASS 35—ADVERTISING AND BUSINESS
FOR RETAIL STORE SERVICES, INCLUDING ON-
LINE RETAIL STORE SERVICES, FEATURING TRIG-
GERS FOR FIREARMS, STICKERS AND ORNAMENTAL
CLOTH PATCHES (U.S. CLS. 100, 101 AND 102).
FIRST USE 12-0-2010; IN COMMERCE 12-0-2010.
KATHRYN COWARD, EXAMINING ATTORNEY
SN 85-236,413. GENOMEDX BIOSCIENCES INC., VANCOU-
VER, CANADA, FILED 2-8-2011.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
CLASS 5—PHARMACEUTICALS
FOR DIAGNOSTIC TESTING KITS COMPRISED OF
MEDICAL DIAGNOSTIC REAGENTS AND ASSAYS,
AND PRIMERS, PROBES AND ENZYMES FOR MEDI-
CAL PURPOSES, NAMELY, FOR TESTING GENOMIC
EXPRESSION AND SEQUENCING FOR UROLOGIC
CANCERS (U.S. CLS. 6, 18, 44, 46, 51 AND 52).
CLASS 42—SCIENTIFIC AND COMPUTER
SERVICES
FOR PROVIDING LABORATORY TESTING SERVICES
BASED ON GENOMIC EXPRESSION AND SEQUEN-
CING FOR UROLOGIC CANCERS; PROVIDING RE-
SEARCH INFORMATION IN THE NATURE OF
SCIENTIFIC RESEARCH AND TECHNICAL RESEARCH
INFORMATION FOR DISEASE CLASSIFICATION,
PROGNOSIS AND TREATMENT RESPONSE PREDIC-
TION, ALL IN THE FIELD OF UROLOGIC ONCOLOGY;
PROVIDING MEDICAL TESTING SERVICES AND IN-
FORMATION IN THE FIELD OF UROLOGIC ONCOL-
OGY RESEARCH AND DISEASE CLASSIFICATION (U.S.
CLS. 100 AND 101).
CLASS 44—MEDICAL, BEAUTY AND AGRI-
CULTURAL SERVICES
FOR PROVIDING MEDICAL TESTING FOR DIAG-
NOSTIC AND TREATMENT PURPOSES, NAMELY, FOR
DISEASE CLASSIFICATION, PROGNOSIS AND TREAT-
MENT RESPONSE PREDICTION, IN THE FIELD OF
UROLOGIC ONCOLOGY (U.S. CLS. 100 AND 101).
ERIN FALK, EXAMINING ATTORNEY
SN 85-237,981. MONITISE GROUP LIMITED, LONDON,
UNITED KINGDOM, FILED 2-9-2011.
OWNER OF ERPN CMNTY TM OFC REG. NO. 009188012,
DATED 11-30-2010, EXPIRES 6-18-2020.
THE COLOR(S) BLACK AND YELLOW IS/ARE CLAIMED
AS A FEATURE OF THE MARK.
THE MARK CONSISTS OF THE LETTER "M" IN BLACK
WITH A DESIGN OF A YELLOW RIBBON TO THE RIGHT
AND LEFT OF THE LETTER "M".
CLASS 9—ELECTRICAL AND SCIENTIFIC
APPARATUS
FOR (BASED ON USE IN COMMERCE) (BASED ON
44(E)) COMPUTER SOFTWARE FOR ENABLING BANK-
ING AND PAYMENTS TRANSACTIONS VIA MOBILE
TELEPHONES, AND FOR FACILITATING COMMUNI-
CATION VIA A GLOBAL COMPUTER NETWORK;
(BASED ON INTENT TO USE) (BASED ON 44(E)) SOFT-
WARE FOR NEAR FIELD COMMUNICATION (NFC)
TECHNOLOGY-ENABLED READERS AND DEVICES,
NAMELY, MOBILE TELEPHONES, SMART CARD
READERS, AND PROXIMITY PAYMENT PROCESSING
DEVICES ALL USING NEAR FIELD COMMUNICATION
TECHNOLOGY, SAID SOFTWARE BEING FOR USE IN
ENABLING PAYMENT TRANSACTIONS AND DATA
TRANSFER, AND FOR IDENTITY AUTHENTICATION;
NEAR FIELD COMMUNICATION DEVICES, NAMELY,
MOBILE TELEPHONES, SMART CARD READERS, AND
PROXIMITY PAYMENT DEVICES KNOWN AS EN-
CODED CONTACTLESS SMART CARDS CONTAINING
PROGRAMMING USED TO ENABLE PAYMENT
TRANSACTIONS AND DATA TRANSFER, AND FOR
IDENTITY AUTHENTICATION (U.S. CLS. 21, 23, 26, 36
AND 38).
FIRST USE 7-1-2009; IN COMMERCE 7-1-2009.